Longitudinal quantitative magnetic resonance imaging in adrenomyeloneuropathy

Authors:

Abstract
Background Adrenomyeloneuropathy (AMN) is the most frequent metabolic hereditary spastic paraplegia. Accordingly, its main site of pathological changes is the spinal cord. It is difficult to quantify AMN progression, because commonly used clinical scales have limitations, and reliable biomarkers are lacking. Our goal was to investigate whether spinal cord and brain quantitative MRI may assess structural changes in AMN over a relatively short‐time period. Methods In this longitudinal observational study, we assessed the total cord areas (TCAs) from C2‐C3 to T2‐T3 level, and diffusion tensor imaging (DTI) metrics of the cervical spinal cord and brain portion of the corticospinal tracts in six AMN and six age‐matched control subjects at baseline and at a mean follow‐up of 22.6 months. Results Only in AMN patients, we observed a significant reduction of the mean TCA at T1‐T2 level (‐3.79%), and a trend of reduction at the lowest cervical levels. Additionally, DTI metrics revealed significant changes in fractional anisotropy (‐8.84%), mean diffusivity (+12.62%) and radial diffusivity (+25.91%) at C2‐C3 level. Discussion Our study encourages the assessment of TCAs and spinal cord DTI metrics as surrogate outcome measures in AMN, by focusing on the cervical‐thoracic junction and uppermost part of cervical spinal cord. Despite the limitation of the results due to the small number of investigated subjects, these observations are useful for forthcoming clinical trials in AMN and possibly other hereditary diseases with predominant spinal cord involvement.